Psychiatry and Neurology, Epilepsy · Stanford, CA
NPI
1184653487
Since 2006
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
6
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Pasteur Dr
Stanford, CA, 94305
Phone (650) 723-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
251 services
Medicare patients, 2024
135
Average age 73
Drug cost, 2024
$238K
464 prescriptions
Company payments, 2025
$60.79
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael B Westover was code 95720 (neurologic), 129 times for 68 patients. In total Michael B Westover billed 251 services in 15 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 129 | 68 | $171.92 | $22K |
| 95718 Neurologic | Facility | 44 | 43 | $103.84 | $4,569 |
| 99215 Office E&M - Established | Facility | 31 | 25 | $106.52 | $3,302 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 13 | $97.38 | $1,948 |
By year: 2022 $26K for 206 services; 2023 $38K for 276 services; 2024 $35K for 251 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael B Westover prescribed most often to Medicare patients was Levetiracetam, with 72 prescriptions and refills. In total Michael B Westover wrote 464 Medicare prescriptions that cost $238K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 72 | 145 | 18 | $2,139 |
| Clobazam Generic | 45 | 53 | Under 11 | $3,356 |
| Lamotrigine Generic | 32 | 59 | Under 11 | $916 |
| Aptiom Eslicarbazepine Acetate | 26 | 26 | Under 11 | $32K |
| Zonisamide Generic | 24 | 60 | Under 11 | $998 |
| Lacosamide Generic | 23 | 27 | Under 11 | $873 |
| Phenobarbital Generic | 21 | 39 | Under 11 | $889 |
| Clonazepam Generic | 20 | 22 | Under 11 | $225 |
| Topiramate Generic | 20 | 34 | Under 11 | $411 |
| Lorazepam Generic | 19 | 21 | Under 11 | $81.4 |
| Divalproex Sodium Generic | 19 | 25 | Under 11 | $545 |
| Banzel Rufinamide | 19 | 19 | Under 11 | $121K |
| Levetiracetam Er Levetiracetam | 18 | 30 | Under 11 | $1,441 |
| Paroxetine Hcl Generic | 13 | 13 | Under 11 | $81.57 |
| Epidiolex Cannabidiol (Cbd) | 11 | 12 | Under 11 | $39K |
Brand drugs: 72 claims; generic drugs: 371 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael B Westover $60.79 ($60.79 in general payments such as food, travel and fees) from 2 companies. The largest payer was Jazz Pharmaceuticals Inc. with $60.79.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 2 | $60.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.